“ RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms ”, Braz. J. Pharm. Sci., vol. 49, no. 2, pp. 359–366, Jun. 2013, doi: 10.1590/S1984-82502013000200018.